Results 181 to 190 of about 295,380 (280)

Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response. [PDF]

Leukemia
Terziev D, Schümann FL, Behlendorf T, Brunner F, Eisenmann S, Groß E, Heuser M, Weber T.   +7 more
europepmc   +1 more source

Low tumor burden follicular lymphoma: The state of the art

HemaSphere, Volume 10, Issue 11, November 2026.
Abstract Follicular lymphoma (FL) is the commonest indolent non‐Hodgkin lymphoma. Most patients present with advanced‐stage and are stratified by the Groupe d'Etude des Lymphomes Folliculaires (GELF) criteria into high or low tumor burden (LTB). Randomized trials in LTB FL demonstrated no overall survival advantage with immediate treatment compared to ...
Greg Hapgood, Joshua Tobin, Robert Kridel, Brad Kahl   +3 more
wiley   +1 more source

Simultaneous DOTATATE uptake in three non-neuroendocrine pathologies: Follicular lymphoma, Crohn's disease, and vertebral hemangioma. [PDF]

Radiol Case Rep
Khabaz K, Said JW, Chiang J.
europepmc   +1 more source

Personalizing Maintenance Rituximab in Follicular Lymphoma: A Machine Learning Framework for Risk-Benefit Optimization. [PDF]

Health Data Sci
Gao J, Liu J, Li X, Wu M, Cui R, Huang Y, Zhang Z, Zhu Y, Wang Y, Song Y, Harrison EM, Mi L, Ma L, Xie Y.   +13 more
europepmc   +1 more source

Highlights: Follicular lymphoma

Journal of Clinical and Experimental Hematopathology, 2023
openaire   +2 more sources

Non‐Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis

Hematological Oncology, Volume 44, Issue 6, November 2026.
ABSTRACT Bispecific antibodies (BsAbs) redirect T‐cells to tumor antigens in an MHC‐independent manner. These universally available, off‐the‐shelf products have demonstrated unprecedented efficacy in heavily pretreated patients with relapsed/refractory (R/R) hematological malignancies (HMs).
Sohaib Irfan, Harshit Khosla, Saad Nasir, Manmeet Kaur, Tyler J. Varisco, Onyebuchi Ononogbu, Sharda Singh, Muhammad Bilal Abid   +7 more
wiley   +1 more source

Comparative Analysis of the Clinicopathological Features of Follicular Lymphoma With and Without EZH2 Y646 Mutation. [PDF]

Pathol Int
Satou A, Yoshikawa K, Mitsuda I, Iwakoshi A, Minoshima M, Gunji M, Murakami H, Carreras J, Ikoma H, Nakamura N, Tsuzuki T, Sato M, Karube K.   +12 more
europepmc   +1 more source

Chylous Ascites: A Rare Initial Presentation of High-Grade Follicular Lymphoma. [PDF]

Case Rep Oncol Med
Nada R, Gvajaia A, Raza A, Raji M.
europepmc   +1 more source

Identification of a Glycosylation‐Related Gene Prognostic Signature for Non–Small Cell Lung Cancer

The Journal of Gene Medicine, Volume 28, Issue 11, November 2026.
A ten‐glycosylation‐related‐gene (GRG) prognostic signature for non‐small cell lung cancer (NSCLC) was constructed using TCGA data. Differentially expressed GRGs were screened and refined by Cox and LASSO regression. The ten‐gene signature (including ADAMTS15, PCSK9, MUC2, and B3GNT3) stratified patients into high‐ and low‐risk groups with distinct ...
Qingtao Zhao, Xiaopeng Zhang, Guochen Duan   +2 more
wiley   +1 more source

LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma. [PDF]

Br J Haematol
Barge L, Webb L, Pelecanos A, Waters N, Salvaris R, Lai S, Potezny T, Cashman H, Nguyen-Ngo C, Lee D, Yannakou CK, Hamad N, Chauchet A, Choquet S, Rossi C, Herbin A, Kanagaratnam L, Rodier C, Tam CS, Bhattacharyya A, Cheah CY, Hawkes EA, Morris K, Durot E, Tobin J, Hapgood G.   +25 more
europepmc   +1 more source